SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.036B
March 31, 2026 1.060B
December 31, 2025 1.268B
September 30, 2025 1.489B
June 30, 2025 1.693B
March 31, 2025 1.895B
December 31, 2024 1.910B
September 30, 2024 1.874B
June 30, 2024 1.857B
March 31, 2024 1.842B
December 31, 2023 1.814B
September 30, 2023 1.812B
June 30, 2023 1.805B
March 31, 2023 1.803B
December 31, 2022 1.634B
September 30, 2022 1.445B
June 30, 2022 1.263B
March 31, 2022 1.104B
December 31, 2021 1.117B
September 30, 2021 1.132B
June 30, 2021 1.132B
March 31, 2021 1.080B
December 31, 2020 1.041B
September 30, 2020 1.012B
June 30, 2020 998.61M
Date Value
March 31, 2020 1.021B
December 31, 2019 1.022B
September 30, 2019 1.031B
June 30, 2019 1.108B
March 31, 2019 1.152B
December 31, 2018 1.182B
September 30, 2018 1.200B
June 30, 2018 1.134B
March 31, 2018 1.058B
December 31, 2017 1.011B
September 30, 2017 972.83M
June 30, 2017 959.29M
March 31, 2017 970.09M
December 31, 2016 975.12M
September 30, 2016 968.07M
June 30, 2016 954.71M
March 31, 2016 942.50M
December 31, 2015 933.60M
September 30, 2015 941.32M
June 30, 2015 940.85M
March 31, 2015 935.19M
December 31, 2014 926.98M
September 30, 2014 904.87M
June 30, 2014 884.84M
March 31, 2014 871.54M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Henry Schein, Inc. 3.208B
Fuse Medical, Inc. --
Cencora, Inc. 7.654B
Cardinal Health, Inc. 6.132B
McKesson Corp. 8.164B